IL183983A0 - Processes for producing 4-aminoquinazoline derivatives - Google Patents
Processes for producing 4-aminoquinazoline derivativesInfo
- Publication number
- IL183983A0 IL183983A0 IL183983A IL18398307A IL183983A0 IL 183983 A0 IL183983 A0 IL 183983A0 IL 183983 A IL183983 A IL 183983A IL 18398307 A IL18398307 A IL 18398307A IL 183983 A0 IL183983 A0 IL 183983A0
- Authority
- IL
- Israel
- Prior art keywords
- processes
- producing
- aminoquinazoline derivatives
- aminoquinazoline
- derivatives
- Prior art date
Links
- DRYRBWIFRVMRPV-UHFFFAOYSA-N quinazolin-4-amine Chemical class C1=CC=C2C(N)=NC=NC2=C1 DRYRBWIFRVMRPV-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
- C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
- C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D265/24—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in positions 2 and 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/40—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings
- C07C271/58—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/88—Oxygen atoms
- C07D239/91—Oxygen atoms with aryl or aralkyl radicals attached in position 2 or 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/94—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US63727804P | 2004-12-17 | 2004-12-17 | |
| PCT/US2005/045506 WO2006066044A2 (en) | 2004-12-17 | 2005-12-15 | Processes for producing 4-aminoquinazolines |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL183983A0 true IL183983A0 (en) | 2007-10-31 |
| IL183983A IL183983A (en) | 2012-04-30 |
Family
ID=36588571
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL183983A IL183983A (en) | 2004-12-17 | 2007-06-17 | Processes for producing 4-aminoquinazoline derivatives |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US20060166963A1 (en) |
| EP (2) | EP2366696A1 (en) |
| JP (2) | JP5030787B2 (en) |
| KR (1) | KR20070091660A (en) |
| CN (1) | CN101111487A (en) |
| AR (1) | AR053317A1 (en) |
| AT (1) | ATE549314T1 (en) |
| AU (1) | AU2005316454B2 (en) |
| BR (1) | BRPI0519600A2 (en) |
| CA (1) | CA2591588A1 (en) |
| ES (1) | ES2382200T3 (en) |
| IL (1) | IL183983A (en) |
| MX (1) | MX2007007446A (en) |
| PL (1) | PL382927A1 (en) |
| RU (1) | RU2007127315A (en) |
| TW (1) | TW200635905A (en) |
| WO (1) | WO2006066044A2 (en) |
| ZA (1) | ZA200704972B (en) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CL2004000409A1 (en) * | 2003-03-03 | 2005-01-07 | Vertex Pharma | COMPOUNDS DERIVED FROM 2- (REPLACED CILO) -1- (AMINO OR REPLACED OXI) -CHINAZOLINE, INHIBITORS OF IONIC SODIUM AND CALCIUM VOLTAGE DEPENDENTS; PHARMACEUTICAL COMPOSITION; AND USE OF THE COMPOUND IN THE TREATMENT OF ACUTE PAIN, CHRONIC, NEU |
| US7713983B2 (en) * | 2003-03-03 | 2010-05-11 | Vertex Pharmaceuticals Incorporated | Quinazolines useful as modulators of ion channels |
| US7928107B2 (en) * | 2004-09-02 | 2011-04-19 | Vertex Pharmaceuticals Incorporated | Quinazolines useful as modulators of ion channels |
| US7718658B2 (en) * | 2004-09-02 | 2010-05-18 | Vertex Pharmaceuticals Incorporated | Quinazolines useful as modulators of ion channels |
| US8283354B2 (en) * | 2004-09-02 | 2012-10-09 | Vertex Pharmaceuticals Incorporated | Quinazolines useful as modulators of ion channels |
| MX2008006303A (en) * | 2005-11-14 | 2009-02-26 | Vertex Pharma | Quinazolines useful as modulators of voltage gated ion channels. |
| US20070197509A1 (en) * | 2005-12-21 | 2007-08-23 | Painceptor Pharma Corporation | Compositions and methods for modulating gated ion channels |
| WO2008069976A2 (en) | 2006-12-01 | 2008-06-12 | President And Fellows Of Harvard College | Compounds and methods for enzyme-mediated tumor imaging and therapy |
| WO2011024843A1 (en) * | 2009-08-31 | 2011-03-03 | オムロン株式会社 | Multiple optical axis photoelectric sensor |
| CN106632088B (en) * | 2015-10-30 | 2019-04-19 | 华南理工大学 | A kind of aggregation-induced emission probe and its preparation method and application based on quianzolinones |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3637693A (en) * | 1968-07-12 | 1972-01-25 | Du Pont | Hydroxyarylquinazolines and their use as uv-absorbers |
| US3819628A (en) * | 1972-07-31 | 1974-06-25 | Sandoz Ag | 2-phenyl-4-substituted amino-quinazolines and nitrates thereof |
| DE19756388A1 (en) * | 1997-12-18 | 1999-06-24 | Hoechst Marion Roussel De Gmbh | New 2-aryl-4-amino-6,7-di:methoxy-quinazoline derivatives useful as guanylate cyclase activators for treating cardiovascular diseases, etc. |
| US6184226B1 (en) * | 1998-08-28 | 2001-02-06 | Scios Inc. | Quinazoline derivatives as inhibitors of P-38 α |
| US6608053B2 (en) * | 2000-04-27 | 2003-08-19 | Yamanouchi Pharmaceutical Co., Ltd. | Fused heteroaryl derivatives |
| US6813772B2 (en) * | 2000-09-29 | 2004-11-02 | Matsushita Electric Industrial Co., Ltd. | Optical disk drive |
| CL2004000409A1 (en) * | 2003-03-03 | 2005-01-07 | Vertex Pharma | COMPOUNDS DERIVED FROM 2- (REPLACED CILO) -1- (AMINO OR REPLACED OXI) -CHINAZOLINE, INHIBITORS OF IONIC SODIUM AND CALCIUM VOLTAGE DEPENDENTS; PHARMACEUTICAL COMPOSITION; AND USE OF THE COMPOUND IN THE TREATMENT OF ACUTE PAIN, CHRONIC, NEU |
| US7713983B2 (en) * | 2003-03-03 | 2010-05-11 | Vertex Pharmaceuticals Incorporated | Quinazolines useful as modulators of ion channels |
| ES2305744T3 (en) * | 2003-03-12 | 2008-11-01 | Millennium Pharmaceuticals, Inc. | DERIVATIVES OF QUINAZOLINE AS INHIBITORS AND TGF-BETA. |
| US7718658B2 (en) * | 2004-09-02 | 2010-05-18 | Vertex Pharmaceuticals Incorporated | Quinazolines useful as modulators of ion channels |
| US8283354B2 (en) * | 2004-09-02 | 2012-10-09 | Vertex Pharmaceuticals Incorporated | Quinazolines useful as modulators of ion channels |
| MX2008006303A (en) * | 2005-11-14 | 2009-02-26 | Vertex Pharma | Quinazolines useful as modulators of voltage gated ion channels. |
-
2005
- 2005-12-15 BR BRPI0519600-0A patent/BRPI0519600A2/en not_active IP Right Cessation
- 2005-12-15 MX MX2007007446A patent/MX2007007446A/en not_active Application Discontinuation
- 2005-12-15 CA CA002591588A patent/CA2591588A1/en not_active Abandoned
- 2005-12-15 ES ES05854269T patent/ES2382200T3/en active Active
- 2005-12-15 EP EP10181554A patent/EP2366696A1/en not_active Withdrawn
- 2005-12-15 WO PCT/US2005/045506 patent/WO2006066044A2/en active Application Filing
- 2005-12-15 JP JP2007546915A patent/JP5030787B2/en not_active Expired - Fee Related
- 2005-12-15 EP EP05854269A patent/EP1828150B1/en not_active Not-in-force
- 2005-12-15 CN CNA2005800475989A patent/CN101111487A/en active Pending
- 2005-12-15 AT AT05854269T patent/ATE549314T1/en active
- 2005-12-15 RU RU2007127315/04A patent/RU2007127315A/en not_active Application Discontinuation
- 2005-12-15 AU AU2005316454A patent/AU2005316454B2/en not_active Expired - Fee Related
- 2005-12-15 ZA ZA200704972A patent/ZA200704972B/en unknown
- 2005-12-15 KR KR1020077016333A patent/KR20070091660A/en not_active Application Discontinuation
- 2005-12-15 US US11/304,238 patent/US20060166963A1/en not_active Abandoned
- 2005-12-15 PL PL382927A patent/PL382927A1/en not_active Application Discontinuation
- 2005-12-16 AR ARP050105321A patent/AR053317A1/en not_active Application Discontinuation
- 2005-12-16 TW TW094144956A patent/TW200635905A/en unknown
-
2007
- 2007-06-17 IL IL183983A patent/IL183983A/en not_active IP Right Cessation
-
2011
- 2011-12-20 JP JP2011278926A patent/JP2012056968A/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| EP2366696A1 (en) | 2011-09-21 |
| WO2006066044A2 (en) | 2006-06-22 |
| AU2005316454B2 (en) | 2012-09-06 |
| BRPI0519600A2 (en) | 2009-02-25 |
| JP2012056968A (en) | 2012-03-22 |
| ATE549314T1 (en) | 2012-03-15 |
| TW200635905A (en) | 2006-10-16 |
| EP1828150A2 (en) | 2007-09-05 |
| AU2005316454A1 (en) | 2006-06-22 |
| ES2382200T3 (en) | 2012-06-06 |
| IL183983A (en) | 2012-04-30 |
| JP5030787B2 (en) | 2012-09-19 |
| ZA200704972B (en) | 2008-09-25 |
| CN101111487A (en) | 2008-01-23 |
| PL382927A1 (en) | 2008-02-04 |
| JP2008524238A (en) | 2008-07-10 |
| WO2006066044A3 (en) | 2007-05-10 |
| CA2591588A1 (en) | 2006-06-22 |
| KR20070091660A (en) | 2007-09-11 |
| RU2007127315A (en) | 2009-01-27 |
| US20060166963A1 (en) | 2006-07-27 |
| AR053317A1 (en) | 2007-05-02 |
| EP1828150B1 (en) | 2012-03-14 |
| MX2007007446A (en) | 2008-01-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL178233A0 (en) | Process for producing 5-hydroxy-4-thiomethylpyrazole derivatives | |
| GB0416001D0 (en) | Process | |
| GB0407329D0 (en) | Process | |
| IL183983A0 (en) | Processes for producing 4-aminoquinazoline derivatives | |
| GB0418654D0 (en) | Process | |
| GB0418046D0 (en) | Eantioselective process | |
| GB0404793D0 (en) | Process | |
| GB0413053D0 (en) | Process | |
| GB0414847D0 (en) | Process | |
| GB0419075D0 (en) | Process | |
| IL178069A0 (en) | Process for preparing n-aryl-piperazine derivatives | |
| GB0406894D0 (en) | Process | |
| GB0410289D0 (en) | Process | |
| EP1754738A4 (en) | Process for producing polypyridinium | |
| GB0412875D0 (en) | Process | |
| GB0414335D0 (en) | Process | |
| EP1914313A4 (en) | Method for producing cercosporamide | |
| ZA200709013B (en) | Method for producing 2-isopropenyl-5-methyl-4-hexen-1-yl 3-methyl-2-butenoate | |
| EP1976858A4 (en) | Method for preparing 4-demethyldaunorubicin | |
| GB0411583D0 (en) | Process | |
| GB0411185D0 (en) | Process | |
| IL183804A0 (en) | Process for preparing substituted 2-alkoxycarbonyl-3-aminothiophenes | |
| EP1903047A4 (en) | Method for producing trihydrocarbylborane | |
| GB0413084D0 (en) | Process | |
| GB0401540D0 (en) | Process |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| MM9K | Patent not in force due to non-payment of renewal fees |